Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:1948-55.

Slides:

Advertisements

Similar presentations

Sibbing D, et al. J Am Coll Cardiol 2009;53:

Advertisements

Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:

Flow diagram showing study population of Chinese patients with type 2 diabetes mellitus and reasons for exclusion Yang X et al. CMAJ 2008;179:

Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.

Quartiles of complete blood count components Jeffrey L. Anderson, et al. Am J Cardiol 2007;99:

Nearly 5 Million Americans Have CHF 400,000 new onset cases diagnosed annually 1400,000 new onset cases diagnosed annually 1 Over 250,000 deaths annually.

Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:

Cerebro-Vascular Pathology of Elderly diabetics 72 case-studies S. Hannat - R. Chermat - R. Malek Internal Medical Service University Hospital Centre Setif.

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Selective heart rate reduction with ivabradine unloads the left ventricle in.

Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.

Participant Characteristics by Lowest Leg AAI Category Ann M. O’Hare, et al, Circulation 2006;113;

Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:

Hsia J et al. J Am Coll Cardiol 2011;57: Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:

Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.

Baseline Characteristics of Patients Referred for Stress Myocardial Perfusion Testing by Erectile Function Classification James K. Min, et al, Arch Intern.

ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:

Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.

Baseline Characteristics of 1994 of Men With Incident CHD (1994 to 2000) and Matched Control Subjects From the Health Professionals Follow-up Study T.

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.

Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Assessment of Coronary Plaque Progression in Coronary.

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,

Analysis and Interpretation: Multiple Variables Simultaneously

Adapted from Weiss et al. J Am Coll Cardiol. 1998;31:

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

[Now published J Am Coll Cardiol 2011;57:173–80]

Kuwabara et al. Am J Nephrol 2017;45: (DOI: / )

Atorvastatin 20 mg (n=25 lesions) Atorvastatin 5 mg (n=25 lesions)

TECAM Trial design: STEMI patients who underwent successful reperfusion therapy were randomized on day 1 to intracoronary bone marrow autologous mononuclear.

Figure 2 Three-year survival rates on the basis of body composition

INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.

Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.

Hammoud et al. Am J Nephrol 2016;44: (DOI: / )

SMILE Trial design: NSTEMI patients were randomized to complete revascularization during the index procedure (i.e., 1-stage revascularization; n = 264)

ZEUS Trial design: Patients who were deemed uncertain DES candidates due to bleeding, thrombotic, or restenosis risk were randomized to receive either.

Description of studies for pooled analyses

Fung TT, et al. Circulation 2009;119:

TACTICS-HF Trial design: Patients with acute heart failure (reduced or preserved ejection fraction) were randomized to tolvaptan 30 mg at 0, 24, and 48.

AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top.

Role of Stenting in Acute MI: PAMI Stent Pilot Trial

Hajer GR et al. Atherosclerosis 2009;202:216-24

Baseline Characteristics of 400 Women Who Subsequently Developed Incident Hypertension (Case Subjects) and 400 Women Who Remained Free of Hypertension.

Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.

Clinical Characteristics and Atheroma Burden of Subjects at Baseline Stratified According to Gender Nicholls SJ. et al. J Am Coll Cardiol 2007;49:

Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31.

Baseline Characteristics According to Sex

Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.

Baseline Clinical Characteristics

Baseline Characteristics of Study Subjects

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Baseline Characteristics of Study Populations

Baseline Lipid Parameters and Characteristics Among 3110 Men According to Quintiles of Total Cholesterol Ruben O. Halperin et al, Hypertension 2006;47;45-50.

Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Different Office SBP and DBP Categories Mancia G et al Hypertension. 2005;45:1072.

Baseline Characteristics of the Patients – Part I

Baseline Characteristics by hs-CRP

IMPRESS Trial design: Patients undergoing primary PCI for STEMI and cardiogenic shock were randomized in a 1:1 to either Impella CP or IABP. They were.

Correlation of biological variance between patients and tissue types.

Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.

Anuurad E, et al. Am J Cardiol 2009;103:523-7

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.

Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:

Frankel DS, et al. J Am Coll Cardiol. 2009;53:754-62

Characteristics of 3415 patients admitted to hospital with

Distribution of patient baseline characteristics among included studies. Distribution of patient baseline characteristics among included studies. Each.

median of follow-up (month)

Presentation transcript:

Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:

Distribution of Blood Lipid Parameters According to the CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:

Pearson Correlation Analysis for the Association of CET Rate and Biologic Parameters Marianne Zeller, et al. J Am Coll Cardiol 2007;50:

Univariate and Multivariate Analyses for the Association Between the CET Rate, as a Dependent Variable, and Patients Characteristics or Lipid Parameters Marianne Zeller, et al. J Am Coll Cardiol 2007;50:

Pearson Correlation Analysis for the Association for Age at MI Onset and Biologic Parameters (n=347) Marianne Zeller, et al. J Am Coll Cardiol 2007;50:

The Highest CET Rates Are Found Among the Youngest Patients With First MI Marianne Zeller, et al. J Am Coll Cardiol 2007;50:

Age and Blood Lipid Parameters Stratified by Gender (n=347) Marianne Zeller, et al. J Am Coll Cardiol 2007;50: